Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.83B | $4.43B | $4.03B | $4.78B | $3.06B | $1.81B | $1.44B | $1.46B | $982.0M | $969.0M | $54.29B | $48.50B | $41.31B | $39.13B | $36.83B | $33.60B | $30.74B | $28.95B | $25.29B |
| Operating income | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B | $2.06B | $2.02B | $2.34B | $1.85B | $1.71B | $1.07B | $1.36B |
| EBITDAderived | $3.40B | $3.40B | $4.79B | $4.51B | $3.74B | $5.60B | $3.77B | $3.54B | $4.67B | $2.13B | $2.70B | $2.69B | $2.37B | $2.35B | $2.65B | $2.12B | $1.96B | $1.29B | $1.54B |
| Net income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614.0M | $1.28B | $1.15B | $1.23B | $1.22B | $1.42B | $1.10B | $1.04B | $647.2M | $833.7M |
| Basic EPSper diluted share | $9.87 | $10.01 | $20.09 | $22.20 | $22.79 | $25.47 | $20.20 | $12.24 | $16.94 | $4.11 | $8.54 | $7.44 | $7.81 | $7.56 | $8.58 | $6.55 | $6.21 | $3.87 | $5.00 |
| Diluted EPSper diluted share | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 | $8.44 | $7.36 | $7.73 | $7.47 | $8.46 | $6.47 | $6.15 | $3.83 | $4.91 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 23, 2026Form 4 | Shetty Sanjay KPresident, CenterWell | BuyHumana Common | 810 | $185.21 | $150.0K | 11.7K |
| May 14, 2025Form 4 | Rechtin James A.President & CEO | BuyHumana Common · indirect | 6.5K | $229.25 | $1.50M | 30.5K |
| Dec 31, 2024Form 4 | Huval Timothy S.Chief Administrative Officer | SellHumana Common | 3.7K | $256.26 | $948.9K | 8.2K |